High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma
Several lines of evidence indicate that Sirt1, a class III histone deacetylase (HDAC) is implicated in the initiation and progression of malignancies and thus gained attraction as druggable target. Since data on the role of Sirt1 in pancreatic ductal adenocarcinoma (PDAC) are sparse, we investigated...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2013
|
| In: |
BMC cancer
Year: 2013, Jahrgang: 13, Pages: 1-12 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/1471-2407-13-450 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1471-2407-13-450 Verlag, kostenfrei, Volltext: https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-13-450 |
| Verfasserangaben: | Albrecht Stenzinger, Volker Endris, Frederick Klauschen, Bruno Sinn, Katja Lorenz, Arne Warth, Benjamin Goeppert, Volker Ehemann, Alexander Muckenhuber, Carsten Kamphues, Marcus Bahra, Peter Neuhaus and Wilko Weichert |
Search Result 1
High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma
BioMed Central; Springer 2013
Article (Journal)
Book/Monograph
Online Resource